Results 51 to 60 of about 3,798 (162)
Short-term vasoactive agent treatment driven by physicians’ preference in acute esophageal variceal bleeding in a tertiary center [PDF]
Background Vasoactive drugs are frequently used in combination with endoscopic variceal ligation (EVL) in treatment of acute esophageal variceal bleeding (EVB).
Yoen Young Chuah +8 more
doaj +2 more sources
Intraoperative Use of Vasoactive Agents in Non‐Cardiac Surgery: Protocol for a Post Hoc Cohort Study
ABSTRACT Background Intraoperative hypotension is a well‐known clinical condition and often treated with vasoactive agents. Previous cohort studies have indicated that large numbers of patients receive this treatment, but they have been limited to specific surgical populations or single agents.
Emilie Stokholm Bækgaard +6 more
wiley +1 more source
Background In cardiogenic shock (CS), titration of both the choice and dosage of inotropes and vasopressors is crucial. The vasoactive–inotropic score (VIS) quantifies hemodynamic support, while the effect of temporal VIS change on prognosis remains unclear. This study evaluated the association between the vasoactive–inotropic score reduction rate (VRR)
Yi-Le Ning +9 more
wiley +1 more source
Terlipressin-related Ischaemic Necrosis of the Skin: A Rare Complication [PDF]
Terlipressin is used for the treatment of bleeding oesophageal varices and hepatorenal syndrome in patients with cirrhosis. Adverse effects are usually minimal.
Novais, António +4 more
core +1 more source
Severe hyponatraemia to terlipressin treatment.
Terlipressin is a vasopressin analogue. The clinical effect is attributable to affinity to vasopressin-1a receptors. However, it also has affinity to renal vasopressin-2 receptors, which can lead to water retention and dilutional hyponatraemia. We report
Poulsen, Anja +1 more
core +1 more source
AIM OF THE STUDY. Comparative clinical analysis of the efficacy of terlipressin and octreotide as additional drug therapy to mechanical hemostasis with nitinol stent in patients with liver cirrhosis complicated by bleeding from esophageal varices ...
A. Yu. Anisimov, Yu. A. Anisimov
doaj +1 more source
Terlipressin for septic shock patients: a meta-analysis of randomized controlled study
Background Catecholamines are commonly used in septic shock but face limitations of their hypo-responsiveness and adverse events due to high dose. Terlipressin is a synthetic vasopressin analog with greater selectivity for the V1-receptor.
Yibing Zhu +3 more
doaj +1 more source
Background Upper gastrointestinal bleeding (UGIB) is a significant cause of cirrhosis decompensation; however, there is still controversy on risk factors for poor outcomes. This study aims to explore the impact of additional variables, such as liver disease etiology and intensive care unit (ICU) accessibility, on mortality, rebleeding, and infection ...
Mariana Barros Marcondes +7 more
wiley +1 more source
Terlipressin for Hepatorenal Syndrome: A Meta-Analysis of Randomized Trials
Background Hepatorenal syndrome (HRS) is a severe complication of end-stage renal disease whose management still constitutes a big challenge. Various approaches have been used for hepatorenal syndrome treatment, including vasoconstrictor therapy ...
Piergiorgio Messa +7 more
core +2 more sources
Background Esophageal variceal bleeding (EVB) is a serious complication of cirrhosis and a major cause of upper gastrointestinal hemorrhage, carrying substantial risks of mortality and treatment failure. Prognostic scores are essential for guiding management.
Khoa Phuoc Nguyen +4 more
wiley +1 more source

